Assignee
SYNAIRGEN RES LIMITED
GB·0 granted patents·2 pending applications·0 citations·filing 2021–2021
Top patents by PatentIndex Score
2 records- 0154US2023338475A1USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTSSYNAIRGEN RES LIMITED·Filed 2021·Application pending·0 cites
- 0247US2023241177A1Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroidSYNAIRGEN RES LIMITED·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SYNAIRGEN RES LIMITED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →